Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are heterogeneous
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …

Pancreatic neuroendocrine neoplasms (pNENs) are a heterogeneous group of tumors
including well differentiated pancreatic neuroendocrine tumors (pNETs) and …

Simple Summary Peptide receptor radionuclide therapy (PRRT) with [177Lu] Lu-DOTA-
TATE is used to treat gastroenteropancreatic neuroendocrine tumours (GEP-NET) by …

Nuroendocrine neoplasms (NENs) are a group of rare neoplasms originating from dispersed
neuroendocrine cells, mainly of the digestive and respiratory tract, showing characteristic …

It is well documented that dysregulation of microRNAs is a hallmark of human cancers. Thus,
this family of small non-coding regulatory molecules represents an excellent source of …

Background: Computed tomography scan is the current standard cross-sectional imaging
modality for neuroendocrine tumor (NET) workup. Diffusion-weighted magnetic resonance …

Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still
insufficiently understood, and the genetic alterations associated with drug responses have …

Pancreatic neuroendocrine tumors (PNETs), which account for 1% to 2% of all pancreatic
neoplasms, are pathologically heterogeneous and consist of epithelial cells with phenotypic …

Background Gastric carcinoids are slow growing neuroendocrine tumours arising from
enterochromaffin-like (ECL) cells in the corpus of stomach. Although most of these tumours …

Aim: Most studies have considered gastroenteropancreatic neuroendocrine tumors (GEP-
NETs) as a homogenous group of samples or distinguish only gastrointestinal from …